Skip to main content
Log in

Biosurfactins production by Bacillus amyloliquefaciens R3 and their antibacterial activity against multi-drug resistant pathogenic E. coli

  • Original Paper
  • Published:
Bioprocess and Biosystems Engineering Aims and scope Submit manuscript

Abstract

In this work, the anti-Escherichia coli activity of the bioactive substances produced by Bacillus amyloliquefaciens R3 was examined. A new and cheap medium for production of the anti-E. coli substances which contained 20.0 g L−1 soybean powder, 20.0 g L−1 wheat flour, pH 6.0 was developed. A crude surfactant concentration of 0.48 mg mL−1 was obtained after 27 h of 10-L fermentation, and the diameter of the clear zone on the plate seeded with the pathogenic E. coli 2# was 23.3 mm. A preliminary characterization suggested that the anti-E. coli substances produced by B. amyloliquefaciens R3 were the biosurfactins (F1, F2, F3, F4, and F5) with amino acids (GLLVDLL) and hydroxy fatty acids (of 12–15 carbons in length). It was found that all the strains of the pathogenic E. coli showed resistance to several different antibiotics, suggesting that they were the multi-drug resistance and all the strains of the pathogenic E. coli were sensitive to the biosurfactins, indicating that the biosurfactins produced by B. amyloliquefaciens R3 had a broad spectrum of antibacterial activity against the pathogenic E. coli with multi-drug resistant profiles. After the treatment with the purified biosurfactin (F1), the cell membrane of both the whole cells and protoplasts of the E. coli 2# was damaged and the whole cells of the bacterium were broken.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Dobrindt U, Hacker J (2008) Targeting virulence traits: potential strategies to combat extraintestinal pathogenic E. coli infections. Cur Opin Microbiol 11:409–413

    Article  CAS  Google Scholar 

  2. Murray PR, Rosenthal KS, Pfaller MA (2009) Medical microbiology, 6th edn. Mosby Elsevier, Philadelphia, pp 301–315

    Google Scholar 

  3. Mora A, Viso S, Lopez C, Alonso MP, Garcıa-Garrote F, Dabhi G, Mamani R, Herrera A, Marzoa J, Blanco M, Blanco JE, Moulin-Schouleur M, Schouler C, Blanco J (2013) Poultry as reservoir for extraintestinal pathogenic Escherichia coli O45:K1:H7-B2-ST95 in humans. Vet Microbiol 167:506–512

    Article  Google Scholar 

  4. Dheilly A, Devendec LL, Mourand G, Jouy E, Kempf I (2013) Antimicrobial resistance selection in avian pathogenic E. coli during treatment. Vet Microbiol 166:655–658

    Article  CAS  Google Scholar 

  5. Yen CC, Shen CJ, Hsu WH, Chang YH, Lin HT (2011) Lactoferrin: an iron-binding antimicrobial protein against Escherichia coli infection. Biometals 24:585–594

    Article  CAS  Google Scholar 

  6. Wong JH, Hao J, Cao Z, Qiao M, Xu H, Bai Y (2008) An antifungal protein from Bacillus amyloliquefaciens. J Appl Microbiol 105:1888–1898

    Article  CAS  Google Scholar 

  7. Sambrook J, Fritsch EF, Maniatis T (1989) Preparation and analysis of eukaryotic genomic DNA. Molecular cloning: a laboratory manual, 2nd edn. Cold Spring Harbor Laboratory Press, Beijing, pp 367–370

    Google Scholar 

  8. Tamura K, Dudley J, Nei M, Kumar S (2007) MEGA4: molecular evolutionary genetics analysis (MEGA) software version 4.0. Mole Biol Evol 24:1596–1599

    Article  CAS  Google Scholar 

  9. Song B, Rong YJ, Zhao MX, Chi ZM (2013) Antifungal activity of the lipopeptides produced by Bacillus amyloliquefaciens anti-CA against Candida albicans isolated from clinic. Appl Microbiol Biotechnol 97:7141–7150

    Article  CAS  Google Scholar 

  10. Xu HM, Rong YJ, Zhao MX, Song B, Chi ZM (2014) Antibacterial activity of the lipopeptides produced by Bacillus amyloliquefaciens M1 against multidrug-resistant Vibrio spp. isolated from diseased marine animals. Appl Microbiol Biotechnol 98:127–136

    Article  CAS  Google Scholar 

  11. Da MH, Ziesman S, Ratcliffe T, Gill RT, Copley SD (2005) Visualization of protoplast fusion and quantitation of recombination in fused protoplasts of auxotrophic strains of Escherichia coli. Metab Eng 7:45–52

    Article  Google Scholar 

  12. Sun L, Lu Z, Bie X, Lu F, Yang S (2006) Isolation and characterization of a co-producer of fengycins and surfactins, endophytic Bacillus amyloliquefaciens ES-2, from Scutellaria baicalensis Georgi. World J Microbiol Biotechnol 22:1259–1266

    Article  CAS  Google Scholar 

  13. Fernandes PAV, Arruda IRD, Santo AFABD (2007) Antimicrobial activity of surfactants produced by Bacillus subtilis R14 against multidrug-resistant bacteria. Braz J Microbiol 38:704–709

    Article  Google Scholar 

  14. Ramos S, Silva N, Canic M, Capelo-Martinez JL, Brito F, Igrejas G (2013) High prevalence of antimicrobial-resistant Escherichia coli from animals at slaughter: a food safety risk. J Sci Food Agri 93:517–526

    Article  CAS  Google Scholar 

  15. Alvarez F, Castro M, Príncipe A, Borioli G, Fischer S, Mori G (2011) The plant-associated Bacillus amyloliquefaciens strains MEP218 and ARP23 capable of producing the cyclic lipopeptides iturin or surfactin and fengycin are effective in biocontrol of sclerotinia stem rot disease. J Appl Microbiol 112:159–174

    Article  Google Scholar 

  16. Duncan SH, Flint HJ, Stewart CS (1998) Inhibitory activity of gut bacteria against Escherichia coli O157 mediated by dietary plant metabolites. FEMS Microbiol Lett 164:283–288

    Article  CAS  Google Scholar 

  17. Appendini P, Hotchkiss JH (1999) Antimicrobial activity of a 14-residue peptide against Escherichia coli O157:H7. J Appl Microbiol 87:750–756

    Article  CAS  Google Scholar 

  18. Ye X, Li P, Yu Q, Yang Q (2013) Bacillus subtilis inhibition of enterotoxic Escherichia coli-induced activation of MAPK signaling pathways in Caco-2 cells. Ann Microbiol 63:577–581

    Article  CAS  Google Scholar 

  19. Collins JW, Ragione RM, Woodward MJ, Searle LEJ (2009) Application of prebiotics and probiotics in livestock. Springer Sciencet Business Media, LLC, New York, pp 1123–1192

    Book  Google Scholar 

  20. Viscardi M, Perugini AG, Auriemma C, Capuano F, Morabito S (2008) Isolation and characterisation of two novel coliphages with high potential to control antibiotic-resistant pathogenic Escherichia coli (EHEC and EPEC). Intern J Antimicrob Agents 3:152–157

    Article  Google Scholar 

  21. Oelschlaeger T, Dobrindt U, Hacker J (2002) Pathogenicity islands of uropathogenic E. coli and the evolution of virulence. Intern J Antimicrob Agents 19:517–521

    Article  CAS  Google Scholar 

  22. Yang J, Huang K, Qin S, Wu X, Zhao Z, Chen F (2009) Antibacterial action of selenium-enriched probiotics against pathogenic Escherichia coli. Dig Dis Sci 54:246–254

    Article  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by Grant 30771645 from National Natural Science Foundation of China.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zhen-Ming Chi.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chi, Z., Rong, YJ., Li, Y. et al. Biosurfactins production by Bacillus amyloliquefaciens R3 and their antibacterial activity against multi-drug resistant pathogenic E. coli . Bioprocess Biosyst Eng 38, 853–861 (2015). https://doi.org/10.1007/s00449-014-1328-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00449-014-1328-9

Keywords

Navigation